Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
Clinical trial NCT00005652 · COMPLETED
Trial details
- NCT number
- NCT00005652
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-12-01
- Primary completion
- 2007-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.